000 01268 a2200361 4500
005 20250516063956.0
264 0 _c20120105
008 201201s 0 0 eng d
022 _a1526-632X
024 7 _a10.1212/WNL.0b013e318239b9ae
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKyriakides, Theodoros
245 0 0 _aSPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy: predicting the severity of Duchenne muscular dystrophy: implications for treatment.
_h[electronic resource]
260 _bNeurology
_cNov 2011
300 _a1858; author reply 1858-9 p.
_bdigital
500 _aPublication Type: Letter; Comment
650 0 4 _aAnimals
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMuscular Dystrophy, Duchenne
_xdrug therapy
650 0 4 _aOsteopontin
_xgenetics
650 0 4 _aPolymorphism, Single Nucleotide
700 1 _aPegoraro, E
700 1 _aHoffman, E P
700 1 _aPiva, L
700 1 _aCagnin, S
700 1 _aLanfranchi, G
700 1 _aGriggs, Robert C
700 1 _aNelson, Stanley F
773 0 _tNeurology
_gvol. 77
_gno. 20
_gp. 1858; author reply 1858-9
856 4 0 _uhttps://doi.org/10.1212/WNL.0b013e318239b9ae
_zAvailable from publisher's website
999 _c21312480
_d21312480